Renaissance Group’s GeneDx Holdings WGS Stock Holding History

Renaissance Group’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-66,977	Closed	-$4.3M	–	254
2026 Q1	$4.3M	Buy	66,977 +11,874	+22%	+$1.08M	0.18%	127
2025 Q4	$7.17M	Buy	+55,103	New	+$7.56M	0.29%	93

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Renaissance Group's WGS Position: Q2 2026 in Review

Renaissance Group sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 66,977 shares — an estimated $4.3M sold.

Renaissance Group first reported a position in WGS in Q4 2025 and held it in 2 quarters. The position peaked at $7.17M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Renaissance Group reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Renaissance Group sold 66,977 GeneDx Holdings shares in Q2 2026, an estimated $4.3M.
Renaissance Group first reported a position in GeneDx Holdings in Q4 2025 and held it in 2 quarters.
Renaissance Group's GeneDx Holdings position peaked at $7.17M in Q4 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.